Peter Attia
FollowThe latest interviews, podcast appearances, and blog posts from Peter Attia, updated daily.

Understanding reps in reserve | Jeff Cavaliere, M.S.P.T., C.S.C.S.
This clip is from episode # 414 of The Drive which was released on 11/2/26.
#414 ‒ Resistance training as we age: optimizing exercise selection and training intensity for muscle growth, function, and injury risk management | Jeff Cavaliere, M.S.P.T., C.S.C.S.
“Any injury you're dealing with is not a mandate to completely rest. It's not.
Who is actually at risk for CTE?
What autopsy studies can, and cannot, tell us about the risks of repetitive head…
A longevity playbook for building strength and muscle mass
How to train for lasting strength—and keep doing what you love as you age.
#413 ‒ The neuroscience of emotion: challenging conventional theories of emotion, how the brain predicts and constructs our experiences, and gaining greater control over how we feel | Lisa Feldman Barrett, Ph.D.
“What is an emotion? It's a set of predictions that tells a story about what a set of sensory signals mean to you in that situation.”‒ Lisa Feldman…
Personalized medicine comes to cancer immunotherapy
A phase III trial for personalized melanoma vaccination foreshadows a new era of cancer…

412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more
In this episode, Peter welcomes back Dr. Siddhartha Mukherjee, a physician, oncologist, researcher, and the Pulitzer Prize-winning author of The Emperor of All Maladies.
The [almost] unbelievable relationship between “big pharma” and gray-market peptides
We traced the patent and development histories of 25 popular compounds, uncovering ties to the pharmaceutical industry far deeper than their reputation suggests.
#411 ‒ AMA #90: Strong convictions, loosely held: how Peter’s views on fasting, keto, metformin, rapamycin, whole-body MRI, and exercise have changed
“I've been around many really, really great scientists. And one of the characteristics they all have in common is they're not married to a particular thesis being right.
How much do symptomatic treatments for Alzheimer’s disease help?
Cholinesterase inhibitors have been a mainstay of Alzheimer’s treatment for decades. How much cognitive function do they preserve, and what does that mean for patients?